Literature DB >> 15154873

Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis.

Midori Hasegawa1, Nahoko Kawamura, Masamitsu Murase, Shigehisa Koide, Hiroko Kushimoto, Kazutaka Murakami, Makoto Tomita, Yoshiyuki Hiki, Masahiko Shikano, Satoshi Sugiyama.   

Abstract

We evaluated the efficacy of granulocytaperesis and leukocytapheresis for the treatment of rapidly progressive glomerulonephritis (RPGN) and lung hemorrhage caused by microscopic polyangiitis. Three patients with RPGN were treated by granulocytapheresis (GCAP) and five patients with RPGN were treated by leukocytapheresis (LCAP). The prednisolone dose was 0.4 +/- 0.2 g/kg/day (mean +/- SD; range 0.2-0.8 g/kg/day). Pre-treatment serum creatinine was 3.2 +/- 1.4 mg/dL (1.4-5.1 mg/dL). The patients were followed for a mean period of 15 +/- 6 months (6-23 months). Renal function improved in five of the eight RPGN patients. Three lung hemorrhage episodes in two different patients were treated with GCAP and one lung hemorrhage episode was treated with LCAP combined with various doses of corticosteroids. All four lung hemorrhage episodes were ameliorated. We concluded that combined therapy of GCAP or LCAP and corticosteroids is effective for the treatment of RPGN and lung hemorrhage due to microscopic polyangiitis.

Entities:  

Mesh:

Year:  2004        PMID: 15154873     DOI: 10.1111/j.1526-0968.2004.00131.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  De novo antineutrophil cytoplasmic antibody-associated vasculitis in pregnancy: a systematic review on maternal, pregnancy and fetal outcomes.

Authors:  Nicole L Veltri; Michelle Hladunewich; Arrti Bhasin; Jocelyn Garland; Benjamin Thomson
Journal:  Clin Kidney J       Date:  2018-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.